Join the Interacoustics community and receive news about new products, events and much more
This session will explore how cortical auditory evoked potential measurements can be used to inform the management of patients with auditory neuropathy spectrum disorder (ANSD). Whilst traditionally behavioral testing has been required to inform decisions regarding amplification and cochlear implantation, cortical measurements are providing data at earlier ages which is facilitating earlier intervention. The evidence base will be reviewed and best practices will be discussed to help ensure safe and appropriate management decisions are made. Please note there are two identical sessions provided, please select the session that suits your time zone.
Subscribe to our newsletter and receive news on new products, seminars and much more.
By signing up, I accept to receive newsletter e-mails from Interacoustics. I can withdraw my consent at any time by using the ‘unsubscribe’-function included in each e-mail.
Click here and read our privacy notice, if you want to know more about how we treat and protect your personal data.